Abstract
The clinical utility of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has been demonstrated in major head and neck cancers (HNCs) but is unclear in rare HNCs. We therefore evaluated FDG PET in the management of patients with rare HNCs.
Cite
CITATION STYLE
APA
Roh, J.-L., Moon, B. J., Kim, J. S., Lee, J. H., Cho, K.-J., Choi, S.-H., … Kim, S. Y. (2008). Use of 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Rare Head and Neck Cancers. Clinical and Experimental Otorhinolaryngology, 1(2), 103. https://doi.org/10.3342/ceo.2008.1.2.103
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free